Literature DB >> 23596062

Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient.

Oluwole O Awosika1, Jennifer L Lyons, Pedro Ciarlini, Richard E Phillips, Elizabeth D Alfson, Emily L Johnson, Sophia Koo, Francisco Marty, Clifton Drew, Sherif Zaki, Rebecca D Folkerth, Joshua P Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23596062      PMCID： PMC3716475          DOI： 10.1212/WNL.0b013e3182904f96

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies.

Authors:  Debra C Quenelle; Bernhardt Lampert; Deborah J Collins; Terri L Rice; George R Painter; Earl R Kern
Journal:  J Infect Dis       Date:  2010-10-05       Impact factor: 5.226

2.  Fatal adenovirus meningoencephalitis in a bone marrow transplant patient.

Authors:  D Davis; P J Henslee; W R Markesbery
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

3.  Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.

Authors:  Diana F Florescu; Steven A Pergam; Michael N Neely; Fang Qiu; Christine Johnston; SingSing Way; Jane Sande; Deborah A Lewinsohn; Judith A Guzman-Cottrill; Michael L Graham; Genovefa Papanicolaou; Joanne Kurtzberg; Joseph Rigdon; Wendy Painter; Herve Mommeja-Marin; Randall Lanier; Maggie Anderson; Charles van der Horst
Journal:  Biol Blood Marrow Transplant       Date:  2011-09-29       Impact factor: 5.742

Review 4.  Adenovirus.

Authors:  Joseph P Lynch; Michael Fishbein; Marcela Echavarria
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

5.  Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents.

Authors:  Martin Schmidt-Hieber; Julie Schwender; Werner J Heinz; Tatjana Zabelina; Jörn S Kühl; Sabine Mousset; Silke Schüttrumpf; Christian Junghanss; Gerda Silling; Nadezda Basara; Stefan Neuburger; Eckhard Thiel; Igor W Blau
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

Review 6.  Adenovirus infections in immunocompromised patients.

Authors:  D R Carrigan
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965
  6 in total
  5 in total

1.  Human adenovirus meningoencephalitis: a 3-years' overview.

Authors:  Luine Rosele Vidal; Sérgio Monteiro de Almeida; Bárbara Maria Cavalli; Tatiana Gutierrez Dieckmann; Sonia Mara Raboni; Gabriel L O Salvador; Luciane Aparecida Pereira; Indianara Rotta; Meri Bordignon Nogueira
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

2.  Adenovirus diseases: a systematic review and meta-analysis of 228 case reports.

Authors:  Jie Gu; Qing-Qing Su; Ting-Ting Zuo; Yan-Bin Chen
Journal:  Infection       Date:  2020-07-27       Impact factor: 7.455

3.  Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters.

Authors:  Katrin Schaar; Anja Geisler; Milena Kraus; Sandra Pinkert; Markian Pryshliak; Jacqueline F Spencer; Ann E Tollefson; Baoling Ying; Jens Kurreck; William S Wold; Robert Klopfleisch; Karoly Toth; Henry Fechner
Journal:  Mol Ther Nucleic Acids       Date:  2017-07-08       Impact factor: 8.886

Review 4.  Adenoviral Infections in Bone Marrow Transplanted Adult Patients: A Review of the 44 Cases Reported in the Last 25 Years.

Authors:  Stergiani Keramari; Frideriki Poutoglidou; Alexandros Poutoglidis; Damianos Sotiropoulos; Christos Savopoulos; Katerina Chlichlia; Stefanos Chatzis; Angeliki Xagorari; Georgia Kaiafa
Journal:  Cureus       Date:  2021-11-24

5.  Epidemiology of Human Adenoviruses: A 20-Year Retrospective Observational Study in Hospitalized Patients in Bern, Switzerland.

Authors:  Joyce Odeke Akello; Richard Kamgang; Maria Teresa Barbani; Franziska Suter-Riniker; Stephen L Leib; Alban Ramette
Journal:  Clin Epidemiol       Date:  2020-04-05       Impact factor: 4.790
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.